These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 23691498)

  • 1. Application of nanoparticles on diagnosis and therapy in gliomas.
    Hernández-Pedro NY; Rangel-López E; Magaña-Maldonado R; de la Cruz VP; del Angel AS; Pineda B; Sotelo J
    Biomed Res Int; 2013; 2013():351031. PubMed ID: 23691498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
    Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
    Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization.
    Rodà F; Caraffi R; Picciolini S; Tosi G; Vandelli MA; Ruozi B; Bedoni M; Ottonelli I; Duskey JT
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive outlook on intracerebral therapy of malignant gliomas.
    Buonerba C; Di Lorenzo G; Marinelli A; Federico P; Palmieri G; Imbimbo M; Conti P; Peluso G; De Placido S; Sampson JH
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):54-68. PubMed ID: 20888252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment.
    Luiz MT; Delello Di Filippo L; Tofani LB; de Araújo JTC; Dutra JAP; Marchetti JM; Chorilli M
    Int J Pharm; 2021 Jul; 604():120758. PubMed ID: 34090991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could nanoparticle systems have a role in the treatment of cerebral gliomas?
    Caruso G; Caffo M; Alafaci C; Raudino G; Cafarella D; Lucerna S; Salpietro FM; Tomasello F
    Nanomedicine; 2011 Dec; 7(6):744-52. PubMed ID: 21419873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas.
    Chen L; Zhang G; Shi Y; Qiu R; Khan AA
    Curr Pharm Des; 2015; 21(37):5434-49. PubMed ID: 26377659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas.
    Wadajkar AS; Dancy JG; Roberts NB; Connolly NP; Strickland DK; Winkles JA; Woodworth GF; Kim AJ
    J Control Release; 2017 Dec; 267():144-153. PubMed ID: 28887134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional nanoparticles in targeting glioma diagnosis and therapies.
    Li M; Deng H; Peng H; Wang Q
    J Nanosci Nanotechnol; 2014 Jan; 14(1):415-32. PubMed ID: 24730272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection enhanced delivery of cisplatin-loaded brain penetrating nanoparticles cures malignant glioma in rats.
    Zhang C; Nance EA; Mastorakos P; Chisholm J; Berry S; Eberhart C; Tyler B; Brem H; Suk JS; Hanes J
    J Control Release; 2017 Oct; 263():112-119. PubMed ID: 28279797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted brain delivery nanoparticles for malignant gliomas.
    Pinto MP; Arce M; Yameen B; Vilos C
    Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-based cerebral drug-delivery systems and antiangiogenic approach in gliomas treatment.
    Raudino G; Caffo M; Caruso G; Alafaci C; Tomasello F
    Recent Pat Nanotechnol; 2011 Nov; 5(3):239-44. PubMed ID: 21871014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
    da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma.
    Tsai YC; Vijayaraghavan P; Chiang WH; Chen HH; Liu TI; Shen MY; Omoto A; Kamimura M; Soga K; Chiu HC
    Theranostics; 2018; 8(5):1435-1448. PubMed ID: 29507632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
    Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery.
    Zhao YZ; Lin Q; Wong HL; Shen XT; Yang W; Xu HL; Mao KL; Tian FR; Yang JJ; Xu J; Xiao J; Lu CT
    J Control Release; 2016 Feb; 224():112-125. PubMed ID: 26792571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.